|
1
|
Sen R and Baltimore D: Multiple nuclear
factors interact with the immunoglobulin enhancer sequences. Cell.
46:705–716. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Q, Lenardo MJ and Baltimore D: 30
years of NF-κB: A blossoming of relevance to human pathobiology.
Cell. 168:37–57. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Millar MW, Fazal F and Rahman A:
Therapeutic targeting of NF-κB in acute lung injury: A double-edged
sword. Cells. 11:33172022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ivanenkov YA, Balakin KV and Lavrovsky Y:
Small molecule inhibitors of NF-κB and JAK/STAT signal transduction
pathways as promising anti-inflammatory therapeutics. Mini Rev Med
Chem. 11:55–78. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hoffmann A, Natoli G and Ghosh G:
Transcriptional regulation via the NF-kappaB signaling module.
Oncogene. 25:6706–6716. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu P, Li Y, Wang W, Bai Y, Jia H and Yuan
Z: Role and mechanisms of the NF-ĸB signaling pathway in various
developmental processes. Biomed Pharmacother. 153:1135132022.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mulero MC, Huxford T and Ghosh G: NF-κB,
IκB, and IKK: Integral components of immune system signaling. Adv
Exp Med Biol. 1172:207–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Deka K and Li Y: Transcriptional
regulation during aberrant activation of NF-κB signalling in
cancer. Cells. 12:7882023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dolcet X, Llobet D, Pallares J and
Matias-Guiu X: NF-κB in development and progression of human
cancer. Virchows Arch. 446:475–482. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang W, Liu L, Li C, Luo N, Chen R, Li L,
Yu F and Cheng Z: TRIM52 plays an oncogenic role in ovarian cancer
associated with NF-κB pathway. Cell Death Dis. 9:9082018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Man X, Piao C, Lin X, Kong C, Cui X and
Jiang Y: USP13 functions as a tumor suppressor by blocking the
NF-κB-mediated PTEN downregulation in human bladder cancer. J Exp
Clin Cancer Res. 38:2592019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang L, Song L, Xu Y, Xu Y, Zheng M,
Zhang P and Wang Q: Midkine promotes breast cancer cell
proliferation and migration by upregulating NR3C1 expression and
activating the NF-κB pathway. Mol Biol Rep. 49:2953–2961. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wen X, Liu M, Du J and Wang X: Meis
homeobox 2 (MEIS2) inhibits the proliferation and promotes
apoptosis of thyroid cancer cell and through the NF-κB signaling
pathway. Bioengineered. 12:1766–1772. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hou J, Zhuo H, Chen X, Cheng J, Zheng W,
Zhong M and Cai J: MiR-139-5p negatively regulates PMP22 to repress
cell proliferation by targeting the NF-κB signaling pathway in
gastric cancer. Int J Biol Sci. 16:1218–1229. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou JL, Deng S, Fang HS, Yu G and Peng H:
Hsa-let-7g promotes osteosarcoma by reducing HOXB1 to activate
NF-κB pathway. Biomed Pharmacother. 109:2335–2341. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li W, Zhang Z, Zhao W and Han N:
Transglutaminase 3 protein modulates human esophageal cancer cell
growth by targeting the NF-κB signaling pathway. Oncol Rep.
36:1723–1730. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu C, Wang L, Chen W, Zhao S, Yin C, Lin
Y, Jiang A and Zhang P: USP35 activated by miR let-7a inhibits cell
proliferation and NF-κB activation through stabilization of ABIN-2.
Oncotarget. 6:27891–27906. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang K, Liu Y, Eer D, Liu J, Yang F and
Hu K: High CXC chemokine ligand 16 (CXCL16) expression promotes
proliferation and metastasis of lung cancer via regulating the
NF-κB pathway. Med Sci Monit. 24:405–411. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ren C, Han X, Lu C, Yang T, Qiao P, Sun Y
and Yu Z: Ubiquitination of NF-κB p65 by FBXW2 suppresses breast
cancer stemness, tumorigenesis, and paclitaxel resistance. Cell
Death Differ. 29:381–392. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li K, Zhang Z, Mei Y, Yang Q, Qiao S, Ni
C, Yao Y, Li X, Li M, Wei D, et al: Metallothionein-1G suppresses
pancreatic cancer cell stemness by limiting activin A secretion via
NF-κB inhibition. Theranostics. 11:3196–3212. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu W, Lu X, Shi P, Yang G, Zhou Z, Li W,
Mao X, Jiang D and Chen C: TNF-α increases breast cancer stem-like
cells through up-regulating TAZ expression via the non-canonical
NF-κB pathway. Sci Rep. 10:18042020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim RJ, Bae E, Hong YK, Hong JY, Kim NK,
Ahn HJ, Oh JJ and Park DS: PTEN loss-mediated Akt activation
increases the properties of cancer stem-like cell populations in
prostate cancer. Oncology. 87:270–279. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee YS, Lee CH, Bae JT, Nam KT, Moon DB,
Hwang OK, Choi JS, Kim TH, Jun HO, Jung YS, et al: Inhibition of
skin carcinogenesis by suppression of NF-κB dependent ITGAV and
TIMP-1 expression in IL-32γ overexpressed condition. J Exp Clin
Cancer Res. 37:2932018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang X, Yin H, Zhang H, Hu J, Lu H, Li C,
Cao M, Yan S and Cai L: NF-κB-driven improvement of EHD1
contributes to erlotinib resistance in EGFR-mutant lung cancers.
Cell Death Dis. 9:4182018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gao X, Xu F, Zhang HT, Chen M, Huang W,
Zhang Q, Zeng Q and Liu L: PKCα-GSK3β-NF-κB signaling pathway and
the possible involvement of TRIM21 in TRAIL-induced apoptosis.
Biochem Cell Biol. 94:256–264. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Duan J, Lang Y, Song C, Xiong J, Wang Y
and Yan Y: siRNA targeting of PRDX3 enhances cisplatin-induced
apoptosis in ovarian cancer cells through the suppression of the
NF-κB signaling pathway. Mol Med Rep. 7:1688–1694. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Y, Wu J, Jing H, Huang G, Sun Z and
Xu S: Long noncoding RNA MEG3 inhibits breast cancer growth via
upregulating endoplasmic reticulum stress and activating NF-κB and
p53. J Cell Biochem. 120:6789–6797. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rangel M, Kong J, Bhatt V, Khayati K and
Guo JY: Autophagy and tumorigenesis. FEBS J. 289:7177–7198. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Orlandi G, Roncucci L, Carnevale G and
Sena P: Different roles of apoptosis and autophagy in the
development of human colorectal cancer. Int J Mol Sci.
24:102012023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Verzella D, Pescatore A, Capece D,
Vecchiotti D, Ursini MV, Franzoso G, Alesse E and Zazzeroni F:
Life, death, and autophagy in cancer: NF-κB turns up everywhere.
Cell Death Dis. 11:2102020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang B, Mao JH, Wang BY, Wang LX, Wen HY,
Xu LJ, Fu JX and Yang H: Exosomal miR-1910-3p promotes
proliferation, metastasis, and autophagy of breast cancer cells by
targeting MTMR3 and activating the NF-κB signaling pathway. Cancer
Lett. 489:87–99. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim JY, Shin JH, Kim MJ, Kang Y, Lee JS,
Son J, Jeong SK, Kim D, Kim DH, Chun E and Lee KY: β-arrestin 2
negatively regulates lung cancer progression by inhibiting the
TRAF6 signaling axis for NF-κB activation and autophagy induced by
TLR3 and TLR4. Cell Death Dis. 14:4222023. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu S, Huttad L, He G, He W, Liu C, Cai D,
Chen H and Qiu J: Long noncoding RNA HULC regulates the NF-κB
pathway and represents a promising prognostic biomarker in liver
cancer. Cancer Med. 12:5124–5136. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Taniguchi K and Karin M: NF-κB,
inflammation, immunity and cancer: Coming of age. Nat Rev Immunol.
18:309–324. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y
and Li Y: Inflammation and tumor progression: Signaling pathways
and targeted intervention. Signal Transduct Target Ther. 6:2632021.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yu H, Lin L, Zhang Z, Zhang H and Hu H:
Targeting NF-κB pathway for the therapy of diseases: Mechanism and
clinical study. Signal Transduct Target Ther. 5:2092020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang Y, Yang L, Jiang S, Yang T, Lan J,
Lei Y, Tan H and Pan K: HMGB1 mediates lipopolysaccharide-induced
inflammation via interacting with GPX4 in colon cancer cells.
Cancer Cell Int. 20:2052020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lin L, Chen S, Wang H, Gao B, Kallakury B,
Bhuvaneshwar K, Cahn K, Gusev Y, Wang X, Wu Y, et al: SPTBN1
inhibits inflammatory responses and hepatocarcinogenesis via the
stabilization of SOCS1 and downregulation of p65 in hepatocellular
carcinoma. Theranostics. 11:4232–4250. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xiao Y and Yu D: Tumor microenvironment as
a therapeutic target in cancer. Pharmacol Ther. 221:1077532021.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fang Z, Meng Q, Xu J, Wang W, Zhang B, Liu
J, Liang C, Hua J, Zhao Y, Yu X and Shi S: Signaling pathways in
cancer-associated fibroblasts: Recent advances and future
perspectives. Cancer Commun (Lond). 43:3–41. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yeung TL, Leung CS, Wong KK, Samimi G,
Thompson MS, Liu J, Zaid TM, Ghosh S, Birrer MJ and Mok SC: TGF-β
modulates ovarian cancer invasion by upregulating CAF-derived
versican in the tumor microenvironment. Cancer Res. 73:5016–5028.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jin Y, Cai Q, Wang L, Ji J, Sun Y, Jiang
J, Wang C, Wu J, Zhang B, Zhao L, et al: Paracrine activin B-NF-κB
signaling shapes an inflammatory tumor microenvironment in gastric
cancer via fibroblast reprogramming. J Exp Clin Cancer Res.
42:2692023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhao T, Zeng J, Xu Y, Su Z, Chong Y, Ling
T, Xu H, Shi H, Zhu M, Mo Q, et al: Chitinase-3 like-protein-1
promotes glioma progression via the NF-κB signaling pathway and
tumor microenvironment reprogramming. Theranostics. 12:6989–7008.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gong H, Chen S, Liu S, Hu Q, Li Y, Li Y,
Li G, Huang K, Li R and Fang L: Overexpressing lipid raft protein
STOML2 modulates the tumor microenvironment via NF-κB signaling in
colorectal cancer. Cell Mol Life Sci. 81:392024. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
He R, He Y, Du R, Liu C, Chen Z, Zeng A
and Song L: Revisiting of TAMs in tumor immune microenvironment:
Insight from NF-κB signaling pathway. Biomed Pharmacother.
165:1150902023. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Morrissey SM, Zhang F, Ding C,
Montoya-Durango DE, Hu X, Yang C, Wang Z, Yuan F, Fox M, Zhang HG,
et al: Tumor-derived exosomes drive immunosuppressive macrophages
in a pre-metastatic niche through glycolytic dominant metabolic
reprogramming. Cell Metab. 33:2040–2058.e10. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cai H, Yan L, Liu N, Xu M and Cai H: IFI16
promotes cervical cancer progression by upregulating PD-L1 in
immunomicroenvironment through STING-TBK1-NF-κB pathway. Biomed
Pharmacother. 123:1097902020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang C and Wu S: BAP1 mutations inhibit
the NF-κB signaling pathway to induce an immunosuppressive
microenvironment in uveal melanoma. Mol Med. 29:1262023. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tan Y, Sun R, Liu L, Yang D, Xiang Q, Li
L, Tang J, Qiu Z, Peng W, Wang Y, et al: Tumor suppressor DRD2
facilitates M1 macrophages and restricts NF-κB signaling to trigger
pyroptosis in breast cancer. Theranostics. 11:5214–5231. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shen Y, Xue C, Li X, Ba L, Gu J, Sun Z,
Han Q and Zhao RC: Effects of gastric cancer cell-derived exosomes
on the immune regulation of mesenchymal stem cells by the NF-κB
signaling pathway. Stem Cells Dev. 28:464–476. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Georgouli M, Herraiz C, Crosas-Molist E,
Fanshawe B, Maiques O, Perdrix A, Pandya P, Rodriguez-Hernandez I,
Ilieva KM, Cantelli G, et al: Regional activation of myosin II in
cancer cells drives tumor progression via a secretory cross-talk
with the immune microenvironment. Cell. 176:757–774.e23. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Li Y, Zhao B, Peng J, Tang H, Wang S, Peng
S, Ye F, Wang J, Ouyang K, Li J, et al: Inhibition of NF-κB
signaling unveils novel strategies to overcome drug resistance in
cancers. Drug Resist Updat. 73:1010422024. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Goka ET, Chaturvedi P, Lopez DTM, Garza A
and Lippman ME: RAC1b overexpression confers resistance to
chemotherapy treatment in colorectal cancer. Mol Cancer Ther.
18:957–968. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Azuma K, Ikeda K, Suzuki T, Aogi K,
Horie-Inoue K and Inoue S: TRIM47 activates NF-κB signaling via
PKC-ε/PKD3 stabilization and contributes to endocrine therapy
resistance in breast cancer. Proc Natl Acad Sci USA.
118:e21007841182021. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang M, Zhang Y, Xu Z, Qian P, Sun W, Wang
X, Jian Z, Xia T, Xu Y and Tang J: RelB sustains endocrine
resistant malignancy: An insight of noncanonical NF-κB pathway into
breast cancer progression. Cell Commun Signal. 18:1282020.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Peng S, Wang R, Zhang X, Ma Y, Zhong L, Li
K, Nishiyama A, Arai S, Yano S and Wang W: EGFR-TKI resistance
promotes immune escape in lung cancer via increased PD-L1
expression. Mol Cancer. 18:1652019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Somani VK, Zhang D, Dodhiawala PB, Lander
VE, Liu X, Kang LI, Chen HP, Knolhoff BL, Li L, Grierson PM, et al:
IRAK4 signaling drives resistance to checkpoint immunotherapy in
pancreatic ductal adenocarcinoma. Gastroenterology. 162:2047–2062.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Gao Z, Xu J, Fan Y, Zhang Z, Wang H, Qian
M, Zhang P, Deng L, Shen J, Xue H, et al: ARPC1B promotes
mesenchymal phenotype maintenance and radiotherapy resistance by
blocking TRIM21-mediated degradation of IFI16 and HuR in glioma
stem cells. J Exp Clin Cancer Res. 41:3232022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Kumar S, Nandi A, Singh S, Regulapati R,
Li N, Tobias JW, Siebel CW, Blanco MA, Klein-Szanto AJ, Lengner C,
et al: Author correction: Dll1+ quiescent tumor stem cells drive
chemoresistance in breast cancer through NF-κB survival pathway.
Nat Commun. 13:39272022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Liang Y, Wang Y, Zhang Y, Ye F, Luo D, Li
Y, Jin Y, Han D, Wang Z, Chen B, et al: HSPB1 facilitates
chemoresistance through inhibiting ferroptotic cancer cell death
and regulating NF-κB signaling pathway in breast cancer. Cell Death
Dis. 14:4342023. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Yu H, Xie M, Meng Z, Lo CY, Chan FL, Jiang
L, Meng X and Yao X: Endolysosomal ion channel MCOLN2 (Mucolipin-2)
promotes prostate cancer progression via IL-1β/NF-κB pathway. Br J
Cancer. 125:1420–1431. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wang W, Li X, Xu Y, Guo W, Yu H, Zhang L,
Wang Y and Chen X: Acetylation-stabilized chloride intracellular
channel 1 exerts a tumor-promoting effect on cervical cancer cells
by activating NF-κB. Cell Oncol (Dordr). 44:557–568. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Nakanishi M, Korechika A, Yamakawa H,
Kawabe N, Nakai K and Muragaki Y: Acidic microenvironment induction
of interleukin-8 expression and matrix metalloproteinase-2/-9
activation via acid-sensing ion channel 1 promotes breast cancer
cell progression. Oncol Rep. 45:1284–1294. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Alaimo A, Genovesi S, Annesi N, De Felice
D, Subedi S, Macchia A, La Manna F, Ciani Y, Vannuccini F, Mugoni
V, et al: Sterile inflammation via TRPM8 RNA-dependent
TLR3-NF-κB/IRF3 activation promotes antitumor immunity in prostate
cancer. EMBO J. 43:780–805. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Bachmann M, Rossa A, Varanita T, Fioretti
B, Biasutto L, Milenkovic S, Checchetto V, Peruzzo R, Ahmad SA,
Patel SH, et al: Pharmacological targeting of the mitochondrial
calcium-dependent potassium channel KCa3.1 triggers cell death and
reduces tumor growth and metastasis in vivo. Cell Death Dis.
13:10552024. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Chen Q, Liu X, Luo Z, Wang S, Lin J, Xie
Z, Li M, Li C, Cao H, Huang Q, et al: Chloride channel-3 mediates
multidrug resistance of cancer by upregulating P-glycoprotein
expression. J Cell Physiol. 234:6611–6623. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Fernández-Gallardo M, Corzo-Lopez A,
Muñoz-Herrera D, Leyva-Leyva M, González-Ramírez R, Sandoval A,
Delgado-Lezama R, Monjaraz E and Felix R: Role of the Ca2+ channel
α2δ-1 auxiliary subunit in proliferation and migration of human
glioblastoma cells. PLoS One. 17:e02791862022. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Wong JH, Ho KH, Nam S, Hsu WL, Lin CH,
Chang CM, Wang JY and Chang WC: Store-operated Ca2+
entry facilitates the lipopolysaccharide-induced cyclooxygenase-2
expression in gastric cancer cells. Sci Rep. 7:128132017.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Xue C, Gao Y, Li X, Zhang M, Yang Y, Han
Q, Sun Z, Bai C and Zhao RC: Mesenchymal stem cells derived from
adipose accelerate the progression of colon cancer by inducing a
MT-CAFs phenotype via TRPC3/NF-κB axis. Stem Cell Res Ther.
13:3352022. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Basson MD, Zeng B, Downey C, Sirivelu MP
and Tepe JJ: Increased extracellular pressure stimulates tumor
proliferation by a mechanosensitive calcium channel and PKC-β. Mol
Oncol. 9:513–526. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Liang L, Liu X, He J, Shao Y, Liu J, Wang
Z, Xia L, Han T and Wu P: Cyanidin-3-glucoside induces mesenchymal
to epithelial transition via activating Sirt1 expression in triple
negative breast cancer cells. Biochimie. 162:107–115. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Rasanen K, Sriswasdi S, Valiga A, Tang HY,
Zhang G, Perego M, Somasundaram R, Li L, Speicher K, Klein-Szanto
AJ, et al: Comparative secretome analysis of epithelial and
mesenchymal subpopulations of head and neck squamous cell carcinoma
identifies S100A4 as a potential therapeutic target. Mol Cell
Proteomics. 12:3778–3792. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Wu W, Wang Y, Niu C, Wahafu A, Huo L, Guo
X, Xiang J, Li X, Xie W, Bai X, et al: Retinol binding protein
1-dependent activation of NF- κB signaling enhances the malignancy
of non-glioblastomatous diffuse gliomas. Cancer Sci. 113:517–528.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Wang Y, Wahafu A, Wu W, Xiang J, Huo L, Ma
X, Wang N, Liu H, Bai X, Xu D, et al: FABP5 enhances malignancies
of lower-grade gliomas via canonical activation of NF-κB signaling.
J Cell Mol Med. 25:4487–4500. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Mi Y, Mu L, Huang K, Hu Y, Yan C, Zhao H,
Ma C, Li X, Tao D and Qin J: Hypoxic colorectal cancer cells
promote metastasis of normoxic cancer cells depending on IL-8/p65
signaling pathway. Cell Death Dis. 11:6102020. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Du R, Liu B, Zhou L, Wang D, He X, Xu X,
Zhang L, Niu C and Liu S: Downregulation of annexin A3 inhibits
tumor metastasis and decreases drug resistance in breast cancer.
Cell Death Dis. 9:1262018. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Holmberg R, Robinson M, Gilbert SF,
Lujano-Olazaba O, Waters JA, Kogan E, Velasquez CLR, Stevenson D,
Cruz LS, Alexander LJ, et al: TWEAK-Fn14-RelB signaling cascade
promotes stem cell-like features that contribute to
post-chemotherapy ovarian cancer relapse. Mol Cancer Res.
21:170–186. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Long X, Hu Y, Duan S, Liu X, Huang W, Liu
X, Xu Q, Song W and Zhou J: MRGBP promotes colorectal cancer
metastasis via DKK1/Wnt/β-catenin and NF-κB/p65 pathways mediated
EMT. Exp Cell Res. 421:1133752022. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Lin X, Yoshikawa N, Liu W, Matsukawa T,
Nakamura K, Yoshihara M, Koya Y, Sugiyama M, Tamauchi S, Ikeda Y,
et al: DDIT4 facilitates lymph node metastasis via the activation
of NF-κB pathway and epithelial-mesenchymal transition. Reprod Sci.
30:2829–2841. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Li L, Li P, Zhang W, Zhou H, Guo E, Hu G
and Zhang L: FERMT1 contributes to the migration and invasion of
nasopharyngeal carcinoma through epithelial-mesenchymal transition
and cell cycle arrest. Cancer Cell Int. 22:702022. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Li J, Deng Z, Wang Z, Wang D, Zhang L, Su
Q, Lai Y, Li B, Luo Z, Chen X, et al: Zipper-interacting protein
kinase promotes epithelial-mesenchymal transition, invasion and
metastasis through AKT and NF-κB signaling and is associated with
metastasis and poor prognosis in gastric cancer patients.
Oncotarget. 6:8323–8338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Li T, Li X, Mao R, Pan L, Que Y, Zhu C,
Jin L and Li S: NLRP2 inhibits cell proliferation and migration by
regulating EMT in lung adenocarcinoma cells. Cell Biol Int.
46:588–598. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Soror AA, Eshagh R, Fahim MR, Jamshidian A
and Monfared GH: Prostate cancer invasion is promoted by the
miR-96-5p-induced NDRG1 deficiency through NF-κB regulation. Klin
Onkol. 38:95–101. 2024.PubMed/NCBI
|
|
86
|
Meng DF, Sun R, Liu GY, Peng LX, Zheng LS,
Xie P, Lin ST, Mei Y, Qiang YY, Li CZ, et al: S100A14 suppresses
metastasis of nasopharyngeal carcinoma by inhibition of NF-κB
signaling through degradation of IRAK1. Oncogene. 39:5307–5322.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Lyu G, Su P, Hao X, Chen S, Ren S, Zhao Z,
Gong Y, Liu Q and Shao C: RECQL4 regulates DNA damage response and
redox homeostasis in esophageal cancer. Cancer Biol Med.
18:120–138. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Wang L, Wu H, Wang L, Zhang H, Lu J, Liang
Z and Liu T: Asporin promotes pancreatic cancer cell invasion and
migration by regulating the epithelial-to-mesenchymal transition
(EMT) through both autocrine and paracrine mechanisms. Cancer Lett.
398:24–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Feng M, Feng J, Chen W, Wang W, Wu X,
Zhang J, Xu F and Lai M: Lipocalin2 suppresses metastasis of
colorectal cancer by attenuating NF-κB-dependent activation of
snail and epithelial mesenchymal transition. Mol Cancer. 15:772016.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Nagaraju GP, Long TE, Park W, Landry JC,
Taliaferro-Smith L, Farris AB, Diaz R and El-Rayes BF: Heat shock
protein 90 promotes epithelial to mesenchymal transition, invasion,
and migration in colorectal cancer. Mol Carcinog. 54:1147–1158.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Ren D, Yang Q, Dai Y, Guo W, Du H, Song L
and Peng X: Oncogenic miR-210-3p promotes prostate cancer cell EMT
and bone metastasis via NF-κB signaling pathway. Mol Cancer.
16:1172017. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Bai Y, Ren C, Wang B, Xue J, Li F, Liu J
and Yang L: LncRNA MAFG-AS1 promotes the malignant phenotype of
ovarian cancer by upregulating NFKB1-dependent IGF1. Cancer Gene
Ther. 29:277–291. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Liu B, Yan S, Jia Y, Ma J, Wu S, Xu Y,
Shang M and Mao A: TLR2 promotes human intrahepatic
cholangiocarcinoma cell migration and invasion by modulating NF-κB
pathway-mediated inflammatory responses. FEBS J. 283:3839–3850.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Liu P, Yang P, Zhang Z, Liu M and Hu S:
Ezrin/NF-κB pathway regulates EGF-induced epithelial-mesenchymal
transition (EMT), metastasis, and progression of osteosarcoma. Med
Sci Monit. 24:2098–2108. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Liu J, Wu Z, Han D, Wei C, Liang Y, Jiang
T, Chen L, Sha M, Cao Y, Huang F, et al: Mesencephalic
astrocyte-derived neurotrophic factor inhibits liver cancer through
small ubiquitin-related modifier (SUMO)ylation-related suppression
of NF-κB/snail signaling pathway and epithelial-mesenchymal
transition. Hepatology. 71:1262–1278. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Wang F, Jiang X and Wang P: NF-κB
interaction long non-coding RNA inhibits migration, invasion and
epithelial-mesenchymal transition of cervical cancer cells through
inhibiting NF-κB signaling pathways. Exp Ther Med. 20:1039–1047.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Liu W, Wang S, Sun Q, Yang Z, Liu M and
Tang H: DCLK1 promotes epithelial-mesenchymal transition via the
PI3K/Akt/NF-κB pathway in colorectal cancer. Int J Cancer.
142:2068–2079. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Cui X, Wang Y, Lan W, Wang S, Cui Y, Zhang
X, Lin Z and Piao J: SPOCK1 promotes metastasis in pancreatic
cancer via NF-κB-dependent epithelial-mesenchymal transition by
interacting with IκB-α. Cell Oncol (Dordr). 45:69–84. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Wang L, Wang L, Zhang H, Lu J, Zhang Z, Wu
H and Liang Z: AREG mediates the epithelial-mesenchymal transition
in pancreatic cancer cells via the EGFR/ERK/NF-κB signalling
pathway. Oncol Rep. 43:1558–1568. 2020.PubMed/NCBI
|
|
100
|
Zhou W, Wang Q, Xu Y, Jiang J, Guo J, Yu H
and Wei W: RMP promotes epithelial-mesenchymal transition through
NF-κB/CSN2/snail pathway in hepatocellular carcinoma. Oncotarget.
8:40373–40388. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Liu W, Wang H, Bai F, Ding L, Huang Y, Lu
C, Chen S, Li C, Yue X, Liang X, et al: IL-6 promotes metastasis of
non-small-cell lung cancer by up-regulating TIM-4 via NF-κB. Cell
Prolif. 53:e127762020. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Ma J, Gao Q, Zeng S and Shen H: Knockdown
of NDRG1 promote epithelial-mesenchymal transition of colorectal
cancer via NF-κB signaling. J Surg Oncol. 114:520–527. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Shen T, Yang Z, Cheng X, Xiao Y, Yu K, Cai
X, Xia C and Li Y: CXCL8 induces epithelial-mesenchymal transition
in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway.
Oncol Rep. 37:2095–2100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Lv N, Shan Z, Gao Y, Guan H, Fan C, Wang H
and Teng W: Twist1 regulates the epithelial-mesenchymal transition
via the NF-κB pathway in papillary thyroid carcinoma. Endocrine.
51:469–477. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Nomura A, Banerjee S, Chugh R, Dudeja V,
Yamamoto M, Vickers SM and Saluja AK: CD133 initiates tumors,
induces epithelial-mesenchymal transition and increases metastasis
in pancreatic cancer. Oncotarget. 6:8313–8322. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Chen Z, Zhong T, Zhong J, Tang Y, Ling B
and Wang L: MicroRNA-129 inhibits colorectal cancer cell
proliferation, invasion and epithelial-to-mesenchymal transition by
targeting SOX4. Oncol Rep. 45:612021. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
He Z, Dong W, Hu J and Ren X: AQP5
promotes hepatocellular carcinoma metastasis via NF-κB-regulated
epithelial-mesenchymal transition. Biochem Biophys Res Commun.
490:343–348. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Ma T, Zhao Z, Wang Z, Wang C and Zhang L:
MiR-940 inhibits migration and invasion of tongue squamous cell
carcinoma via regulatingCXCR2/NF-κB system-mediated
epithelial-mesenchymal transition. Naunyn Schmiedebergs Arch
Pharmacol. 392:1359–1369. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Mei LL, Wang WJ, Qiu YT, Xie XF, Bai J and
Shi ZZ: miR-145-5p suppresses tumor cell migration, invasion and
epithelial to mesenchymal transition by regulating the Sp1/NF-κB
signaling pathway in esophageal squamous cell carcinoma. Int J Mol
Sci. 18:18332017. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Tsuboi K, Matsuo Y, Shamoto T, Shibata T,
Koide S, Morimoto M, Guha S, Sung B, Aggarwal BB, Takahashi H and
Takeyama H: Zerumbone inhibits tumor angiogenesis via NF-κB in
gastric cancer. Oncol Rep. 31:57–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Song L, Chen X, Mi L, Liu C, Zhu S, Yang
T, Luo X, Zhang Q, Lu H and Liang X: Icariin-induced inhibition of
SIRT6/NF-κB triggers redox mediated apoptosis and enhances
anti-tumor immunity in triple-negative breast cancer. Cancer Sci.
111:4242–4256. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Zhang T, Guo S, Zhu X, Qiu J, Deng G and
Qiu C: Alpinetin inhibits breast cancer growth by ROS/NF-κB/HIF-1α
axis. J Cell Mol Med. 24:8430–8440. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Sun X, Chang X, Wang Y, Xu B and Cao X:
Oroxylin A suppresses the cell proliferation, migration, and EMT
via NF-κB signaling pathway in human breast cancer cells. Biomed
Res Int. 2019:92417692019. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Qiu J, Zhang T, Zhu X, Yang C, Wang Y,
Zhou N, Ju B, Zhou T, Deng G and Qiu C: Hyperoside induces breast
cancer cells apoptosis via ROS-mediated NF-κB signaling pathway.
Int J Mol Sci. 21:1312019. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Yu X, Liu Y, Wang Y, Mao X, Zhang Y and
Xia J: Baicalein induces cervical cancer apoptosis through the
NF-κB signaling pathway. Mol Med Rep. 17:5088–5094. 2018.PubMed/NCBI
|
|
116
|
Junmin S, Hongxiang L, Zhen L, Chao Y and
Chaojie W: Ginsenoside Rg3 inhibits colon cancer cell migration by
suppressing nuclear factor kappa B activity. J Tradit Chin Med.
35:440–444. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Li W, Sun L, Lei J, Wu Z, Ma Q and Wang Z:
Curcumin inhibits pancreatic cancer cell invasion and EMT by
interfering with tumor-stromal crosstalk under hypoxic conditions
via the IL-6/ERK/NF-κB axis. Oncol Rep. 44:382–392. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Kumar S, Singh R, Dutta D, Chandel S,
Bhattacharya A, Ravichandiran V and Sukla S: In vitro anticancer
activity of methanolic extract of Justicia adhatoda leaves
with special emphasis on human breast cancer cell line. Molecules.
27:82222022. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
De D, Chowdhury P, Panda SK and Ghosh U:
Leaf extract and active fractions of Dillenia pentagyna
Roxb. Reduce in vitro human cancer cell migration Via NF-κB
pathway. Integr Cancer Ther. 21:153473542211288322022. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Jung EJ, Paramanantham A, Kim HJ, Shin SC,
Kim GS, Jung JM, Hong SC, Chung KH, Kim CW and Lee WS:
Identification of growth factors, cytokines and mediators regulated
by Artemisia annua L. Polyphenols (pKAL) in HCT116
colorectal cancer cells: TGF-β1 and NGF-β attenuate pKAL-induced
anticancer effects via NF-κB p65 upregulation. Int J Mol Sci.
23:15982022. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Jin J, Zhou M, Wang X, Liu M, Huang H, Yan
F, Yu Z, Shu X, Huo X, Feng L, et al: Triptolidenol, isolated from
Tripterygium wilfordii, disrupted NF-κB/COX-2 pathway by
targeting ATP-binding sites of IKKβ in clear cell renal cell
carcinoma. Fitoterapia. 148:1047792021. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Zhen X, Choi HS, Kim JH, Kim SL, Liu R,
Yun BS and Lee DS: Machilin D, a lignin derived from saururus
chinensis, suppresses breast cancer stem cells and inhibits NF-κB
signaling. Biomolecules. 10:2452020. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Wang X, Chen Z, Li X, Jiang ZK, Zhao YQ
and Ping FF: Geraniin suppresses ovarian cancer growth through
inhibition of NF-κB activation and downregulation of Mcl-1
expression. J Biochem Mol Toxicol. 31:2017. View Article : Google Scholar
|
|
124
|
Kong Y, Li F, Nian Y, Zhou Z, Yang R, Qiu
MH and Chen C: KHF16 is a leading structure from cimicifuga foetida
that suppresses breast cancer partially by inhibiting the NF-κB
signaling pathway. Theranostics. 6:875–886. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Huang Y, Liu Z, Li L, Jiang M, Tang Y,
Zhou L, Li J and Chen Y: Sesamin inhibits hypoxia-stimulated
angiogenesis via the NF-κB p65/HIF-1α/VEGFA signaling pathway in
human colorectal cancer. Food Funct. 13:8989–8997. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Jiang H, Chen H, Jin C, Mo J and Wang H:
Nobiletin flavone inhibits the growth and metastasis of human
pancreatic cancer cells via induction of autophagy, G0/G1 cell
cycle arrest and inhibition of NF-κB signalling pathway. J BUON.
25:1070–1075. 2020.PubMed/NCBI
|
|
127
|
Zhang Y, Zhao Y, Ran Y, Guo J, Cui H and
Liu S: Alantolactone exhibits selective antitumor effects in HELA
human cervical cancer cells by inhibiting cell migration and
invasion, G2/M cell cycle arrest, mitochondrial mediated apoptosis
and targeting Nf-κB signalling pathway. J BUON. 24:2310–2315.
2019.PubMed/NCBI
|
|
128
|
Zhang Y, Li G and Ji C: Inhibition of
human cervical cancer cell growth by Salviolone is mediated via
autophagy induction, cell migration and cell invasion suppression,
G2/M cell cycle arrest and downregulation of Nf-κB/m-TOR/PI3K/AKT
pathway. J BUON. 23:1739–1744. 2018.PubMed/NCBI
|
|
129
|
Chou YJ, Lin CC, Hsu YC, Syu JL, Tseng LM,
Chiu JH, Lo JF, Lin CH and Fu SL: Andrographolide suppresses the
malignancy of triple-negative breast cancer by reducing
THOC1-promoted cancer stem cell characteristics. Biochem Pharmacol.
206:1153272022. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Kumar R, Bhardwaj P, Soni M, Singh R,
Choudhary S, Virmani N, Asrani RK, Patial V, Sharma D, Gupta VK and
Tripathi BN: Modulation of mammary tumour progression using murine
model by ethanol root extract of Saussurea costus (falc.)
lipsch. J Ethnopharmacol. 319:1173022024. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Rojo D, Madrid A, Martín SS, Párraga M,
Silva Pinhal MA, Villena J and Valenzuela-Valderrama M: Resveratrol
decreases the invasion potential of gastric cancer cells.
Molecules. 27:30472022. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Chung SS, Wu Y, Okobi Q, Adekoya D, Atefi
M, Clarke O, Dutta P and Vadgama JV: Proinflammatory cytokines IL-6
and TNF-α increased telomerase activity through NF-κB/STAT1/STAT3
activation, and Withaferin A inhibited the signaling in colorectal
cancer cells. Mediators Inflamm. 2017:59584292017. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Han B, Jiang P, Liu W, Xu H, Li Y, Li Z,
Ma H, Yu Y, Li X and Ye X: Role of daucosterol linoleate on breast
cancer: Studies on apoptosis and metastasis. J Agric Food Chem.
66:6031–6041. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Paramanantham A, Kim MJ, Jung EJ, Nagappan
A, Yun JW, Kim HJ, Shin SC, Kim GS and Lee WS: Pretreatment of
anthocyanin from the fruit of vitis coignetiae pulliat acts as a
potent inhibitor of TNF-α effect by inhibiting NF-κB-regulated
genes in human breast cancer cells. Molecules. 25:23962020.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Lin CL, Hsieh SL, Leung W, Jeng JH, Huang
GC, Lee CT, Lee CT and Wu CC:
2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside suppresses human
colorectal cancer cell metastasis through inhibiting NF-κB
activation. Int J Oncol. 49:629–638. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Zhao W, Jiang Y, Jia X, Wang X and Guo Y:
Berbamine inhibits the biological activities of prostate cancer
cells by modulating the ROS/NF-κB axis. Anticancer Agents Med Chem.
23:1626–1633. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Jia W, Luo S, Lai G, Li S, Huo S, Li M and
Zeng X: Homogeneous polyporus polysaccharide inhibits bladder
cancer by polarizing macrophages to M1 subtype in tumor
microenvironment. BMC Complement Med Ther. 21:1502021. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Liu R, Choi HS, Kim SL, Kim JH, Yun BS and
Lee DS: 6-Methoxymellein isolated from carrot (Daucus carota
L.) targets breast cancer stem cells by regulating NF-κB signaling.
Molecules. 25:43742020. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Chen X, Wang Y, Zhang L and Gao Y:
Hydroxysafflor yellow A of Carthamus Tinctorius L.,
represses the malignant development of esophageal cancer cells via
regulating NF-κB signaling pathway. Cell Biochem Biophys.
78:511–520. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Ghasemi F, Shafiee M, Banikazemi Z,
Pourhanifeh MH, Khanbabaei H, Shamshirian A, Amiri Moghadam S,
ArefNezhad R, Sahebkar A, Avan A and Mirzaei H: Curcumin inhibits
NF-κB and Wnt/β-catenin pathways in cervical cancer cells. Pathol
Res Pract. 215:1525562019. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Zhang L, Chinnathambi A, Alharbi SA,
Veeraraghavan VP, Mohan SK and Zhang G: Punicalagin promotes the
apoptosis in human cervical cancer (ME-180) cells through
mitochondrial pathway and by inhibiting the NF-κB signaling
pathway. Saudi J Biol Sci. 27:1100–1106. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Su J, Yan Y, Qu J, Xue X, Liu Z and Cai H:
Emodin induces apoptosis of lung cancer cells through ER stress and
the TRIB3/NF-κB pathway. Oncol Rep. 37:1565–1572. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Han S, Lim SL, Kim H, Choi H, Lee MY, Shim
SY, Le DD, Ha IJ, Lee M and Lee SG: Ethyl acetate fraction of
Osmanthus fragrans var. aurantiacus and its triterpenoids
suppress proliferation and survival of colorectal cancer cells by
inhibiting NF-κB and COX2. J Ethnopharmacol. 319:1173622024.
View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Luo KW, Wei C, Lung WY, Wei XY, Cheng BH,
Cai ZM and Huang WR: EGCG inhibited bladder cancer SW780 cell
proliferation and migration both in vitro and in vivo via
down-regulation of NF-κB and MMP-9. J Nutr Biochem. 41:56–64. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Zhang W, Yin G, Dai J, Sun YU, Hoffman RM,
Yang Z and Fan Y: Chemoprevention by quercetin of oral squamous
cell carcinoma by suppression of the NF-κB signaling pathway in
DMBA-treated hamsters. Anticancer Res. 37:4041–4049.
2017.PubMed/NCBI
|
|
146
|
Yu Z, Gao J, Zhang X, Peng Y, Wei W, Xu J,
Li Z, Wang C, Zhou M, Tian X, et al: Characterization of a
small-molecule inhibitor targeting NEMO/IKKβ to suppress colorectal
cancer growth. Signal Transduct Target Ther. 7:712022. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Lawal B, Kuo YC, Wu AT and Huang HS:
Therapeutic potential of EGFR/mTOR/Nf-kb targeting small molecule
for the treatment of non-small cell lung cancer. Am J Cancer Res.
13:2598–2616. 2023.PubMed/NCBI
|
|
148
|
Véquaud E, Séveno C, Loussouarn D,
Engelhart L, Campone M, Juin P and Barillé-Nion S: YM155 potently
triggers cell death in breast cancer cells through an
autophagy-NF-κB network. Oncotarget. 6:13476–13486. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Wong JH, Lui VW, Umezawa K, Ho Y, Wong EY,
Ng MHL, Cheng SH, Tsang CM, Tsao SW and Chan AT: A small molecule
inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ),
suppresses growth and invasion of nasopharyngeal carcinoma (NPC)
cells. Cancer Lett. 287:23–32. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Wang Z, Li MY, Mi C, Wang KS, Ma J and Jin
X: Mollugin has an anti-cancer therapeutic effect by inhibiting
TNF-α-induced NF-κB activation. Int J Mol Sci. 18:16192017.
View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Wu W, Chen F, Cui X, Yang L, Chen J, Zhao
J, Huang D, Liu J, Yang L, Zeng J, et al: LncRNA NKILA suppresses
TGF-β-induced epithelial-mesenchymal transition by blocking NF-κB
signaling in breast cancer. Int J Cancer. 143:2213–2224. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Jiang Z, Zhang J, Chen F and Sun Y:
MiR-148b suppressed non-small cell lung cancer progression via
inhibiting ALCAM through the NF-κB signaling pathway. Thorac
Cancer. 11:415–425. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Ou J, Meng F, Liu J, Li D, Cao H and Sun
B: Ovatodiolide exerts anticancer effects on human cervical cancer
cells via mitotic catastrophe, apoptosis and inhibition of NF-κB
pathway. J BUON. 25:87–92. 2020.PubMed/NCBI
|
|
154
|
Yin M, Ren X, Zhang X, Luo Y, Wang G,
Huang K, Feng S, Bao X, Huang K, He X, et al: Selective killing of
lung cancer cells by miRNA-506 molecule through inhibiting NF-κB
p65 to evoke reactive oxygen species generation and p53 activation.
Oncogene. 34:691–703. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Ginzburg S, Golovine KV, Makhov PB, Uzzo
RG, Kutikov A and Kolenko VM: Piperlongumine inhibits NF-κB
activity and attenuates aggressive growth characteristics of
prostate cancer cells. Prostate. 74:177–186. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Minocha T, Das M, Rai V, Verma SS,
Awasthee N, Gupta SC, Haldar C and Yadav SK: Melatonin induces
apoptosis and cell cycle arrest in cervical cancer cells via
inhibition of NF-κB pathway. Inflammopharmacology. 30:1411–1429.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Srivastava A, Mishra S, Avadhesh Shekher
A, Rai V, Dhasmana A, Das J, Perenzoni D, Iori R and Gupta SC:
Moringin, an isothiocyanate modulates multiple cellular signalling
molecules in breast cancer cells. Cell Signal. 119:1111812024.
View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Chen X, Yuan XN, Zhang Z, Gong PJ, Yin WN,
Jiang Q, Xu J, Xu XL, Gao Y, Chen WL, et al: Betulinic acid
inhibits cell proliferation and migration in gastric cancer by
targeting the NF-κB/VASP pathway. Eur J Pharmacol. 889:1734932020.
View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Lim JCW, Jeyaraj EJ, Sagineedu SR, Wong
WSF and Stanslas J: SRS06, a new semisynthetic andrographolide
derivative with improved anticancer potency and selectivity,
inhibits nuclear factor-κB nuclear binding in the A549 non-small
cell lung cancer cell line. Pharmacol. 95:70–77. 2015. View Article : Google Scholar
|
|
160
|
El-Deeb NM, Yassin AM, Al-Madboly LA and
El-Hawiet A: A novel purified Lactobacillus acidophilus 20079
exopolysaccharide, LA-EPS-20079, molecularly regulates both
apoptotic and NF-κB inflammatory pathways in human colon cancer.
Microb Cell Fact. 17:292018. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Liu X, Gao Z, Wang X and Shen Y:
Parthenolide targets NF-κB (P50) to inhibit HIF-1α-mediated
metabolic reprogramming of HCC. Aging (Albany NY). 14:8346–8356.
2022.PubMed/NCBI
|
|
162
|
Leung HW, Wang Z, Yue GG, Zhao SM, Lee JK,
Fung KP, Leung PC, Lau CB and Tan NH: Cyclopeptide RA-V inhibits
cell adhesion and invasion in both estrogen receptor positive and
negative breast cancer cells via PI3K/AKT and NF-κB signaling
pathways. Biochim Biophys Acta. 1853:1827–1840. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Chen K, Pan Q, Gao Y, Yang X, Wang S,
Peppelenbosch MP and Kong X: DMS triggers apoptosis associated with
the inhibition of SPHK1/NF-κB activation and increase in
intracellular Ca2+ concentration in human cancer cells. Int J Mol
Med. 33:17–24. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Acuña UM, Mo S, Zi J, Orjala J and DE
Blanco EJC: Hapalindole H induces apoptosis as an inhibitor of
NF-ĸB and affects the intrinsic mitochondrial pathway in PC-3
androgen-insensitive prostate cancer cells. Anticancer Res.
38:3299–3307. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Al-Halabi R, Bou Chedid M, Abou Merhi R,
El-Hajj H, Zahr H, Schneider-Stock R, Bazarbachi A and
Gali-Muhtasib H: Gallotannin inhibits NFĸB signaling and growth of
human colon cancer xenografts. Cancer Biol Ther. 12:59–68. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Zhang T, Yu H, Dong G, Cai L and Bai Y:
Chamaejasmine arrests cell cycle, induces apoptosis and inhibits
nuclear NF-κB translocation in the human breast cancer cell line
MDA-MB-231. Molecules. 18:845–858. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Annamalai G and Suresh K: [6]-Shogaol
attenuates inflammation, cell proliferation via modulate NF-κB and
AP-1 oncogenic signaling in 7,12-dimethylbenz[a]anthracene induced
oral carcinogenesis. Biomed Pharmacother. 98:484–490. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Delma CR, Thirugnanasambandan S,
Srinivasan GP, Raviprakash N, Manna SK, Natarajan M and Aravindan
N: Fucoidan from marine brown algae attenuates pancreatic cancer
progression by regulating p53-NFκB crosstalk. Phytochemistry.
167:1120782019. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Duan M, Hu F, Li D, Wu S and Peng N:
Silencing KPNA2 inhibits IL-6-induced breast cancer exacerbation by
blocking NF-κB signaling and c-Myc nuclear translocation in vitro.
Life Sci. 253:1177362020. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Zhang L, Ruan J, Yan L, Li W, Wu Y, Tao L,
Zhang F, Zheng S, Wang A and Lu Y: Xanthatin induces cell cycle
arrest at G2/M checkpoint and apoptosis via disrupting NF-κB
pathway in A549 non-small-cell lung cancer cells. Molecules.
17:3736–3750. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Zhu J, Zhao J, Yu Z, Shrestha S, Song J,
Liu W, Lan W, Xing J, Liu S, Chen C, et al: Epoxymicheliolide, a
novelguaiane-type sesquiterpene lactone, inhibits NF-κB/COX-2
signaling pathways by targeting leucine 281 and leucine 25 in IKKβ
in renal cell carcinoma. Int J Oncol. 53:987–1000. 2018.PubMed/NCBI
|
|
172
|
Wang R, Ma Y, Zhan S, Zhang G, Cao L,
Zhang X, Shi T and Chen W: B7-H3 promotes colorectal cancer
angiogenesis through activating the NF-κB pathway to induce VEGFA
expression. Cell Death Dis. 11:552020. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Al-Saeedi FJ: Asiaticoside increases
caspase-9 activity in MCF-7 cells and inhibits TNF-α and IL-6
expression in nude mouse xenografts via the NF-κB pathway.
Molecules. 28:21012023. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Shiode Y, Kodama T, Shigeno S, Murai K,
Tanaka S, Newberg JY, Kondo J, Kobayashi S, Yamada R, Hikita H, et
al: TNF receptor-related factor 3 inactivation promotes the
development of intrahepatic cholangiocarcinoma through
NF-κB-inducing kinase-mediated hepatocyte transdifferentiation.
Hepatology. 77:395–410. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Wang P, Xun W, Han T and Cheng Z: FAIM-S
functions as a negative regulator of NF-κB pathway and blocks cell
cycle progression in NSCLC cells. Cell Cycle. 19:3458–3467. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Chang H, Xu Q, Li J, Li M, Zhang Z, Ma H
and Yang X: Lactate secreted by PKM2 upregulation promotes
galectin-9-mediated immunosuppression via inhibiting NF-κB pathway
in HNSCC. Cell Death Dis. 12:7252021. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Karelia DN, Kim S, M KP, Plano D, Amin S,
Lu J and Sharma AK: Novel seleno-aspirinyl compound AS-10 induces
apoptosis, G1 arrest of pancreatic ductal adenocarcinoma cells,
inhibits their NF-κB signaling, and synergizes with gemcitabine
cytotoxicity. Int J Mol Sci. 22:49662021. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Wang X, Wang F, Zhang ZG, Yang XM and
Zhang R: STK3 suppresses ovarian cancer progression by activating
NF-κB signaling to recruit CD8+ T-cells. J Immunol Res.
2020:72636022020. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Yodkeeree S, Pompimon W and Limtrakul P:
Crebanine, an aporphine alkaloid, sensitizes TNF-α-induced
apoptosis and suppressed invasion of human lung adenocarcinoma
cells A549 by blocking NF-κB-regulated gene products. Tumour Biol.
35:8615–8624. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Li J, Zhang ZC, Yuan XS, Tang SS, Wang T,
Liu HF and Cao Y: TOPK affects autophagy of skin squamous cell
carcinoma by regulating NF-KB pathway through HDAC1. Dis Markers.
2022:37717112022.PubMed/NCBI
|
|
181
|
Hai Ping P, Feng Bo T, Li L, Nan Hui Y and
Hong Z: IL-1β/NF-kb signaling promotes colorectal cancer cell
growth through miR-181a/PTEN axis. Arch Biochem Biophys. 604:20–26.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Fang X, Shi H and Sun F: The
microRNA-520a-3p inhibits invasion and metastasis by targeting
NF-kappaB signaling pathway in non-small cell lung cancer. Clin
Transl Oncol. 24:1569–1579. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Sheng YH, He Y, Hasnain SZ, Wang R, Tong
H, Clarke DT, Lourie R, Oancea I, Wong KY, Lumley JW, et al: MUC13
protects colorectal cancer cells from death by activating the NF-κB
pathway and is a potential therapeutic target. Oncogene.
36:700–713. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Yong-Zheng X, Wan-Li M, Ji-Ming M and
Xue-Qun R: Receptor for activated protein kinase C 1 suppresses
gastric tumor progression through nuclear factor-κB pathway. Indian
J Cancer. 52 (Suppl 3):E172–E175. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Barbie TU, Alexe G, Aref AR, Li S, Zhu Z,
Zhang X, Imamura Y, Thai TC, Huang Y, Bowden M, et al: Targeting an
IKBKE cytokine network impairs triple-negative breast cancer
growth. J Clin Invest. 124:5411–5423. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Lim EY, Park J, Kim YT and Kim MJ:
Imipramine inhibits migration and invasion in metastatic
castration-resistant prostate cancer PC-3 cells via AKT-mediated
NF-κB signaling pathway. Molecules. 25:46192020. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Chen MC, Lee NH, Hsu HH, Ho TJ, Tu CC,
Chen RJ, Lin YM, Viswanadha VP, Kuo WW and Huang CY: Inhibition of
NF-κB and metastasis in irinotecan (CPT-11)-resistant LoVo colon
cancer cells by thymoquinone via JNK and p38. Environ Toxicol.
32:669–678. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Xu CY, Qin MB, Tan L, Liu SQ and Huang JA:
NIBP impacts on the expression of E-cadherin, CD44 and vimentin in
colon cancer via the NF-κB pathway. Mol Med Rep. 13:5379–5385.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Zhang J, Zhang DL, Jiao XL and Dong Q:
S100A4 regulates migration and invasion in hepatocellular carcinoma
HepG2 cells via NF-κB-dependent MMP-9 signal. Eur Rev Med Pharmacol
Sci. 17:2372–2382. 2013.PubMed/NCBI
|
|
190
|
Chiu CT, Chen JH, Chou FP and Lin HH:
Hibiscus sabdariffa leaf extract inhibits human prostate
cancer cell invasion via down-regulation of Akt/NF-κB/MMP-9
pathway. Nutrients. 7:5065–5087. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Yi S, Liu G, Wu Y, Liang Q and Li L:
Baicalein suppresses the growth of the human thyroid cancer cells
by inducing mitotic catastrophe, apoptosis and autophagy via NF-κB
signalling pathway. J BUON. 25:389–394. 2020.PubMed/NCBI
|
|
192
|
Sun Y, Pang B, Wang Y, Xiao J and Jiang D:
Baohuoside I inhibits the proliferation of hepatocellular carcinoma
cells via apoptosis signaling and NF-κB pathway. Chem Biodivers.
18:e21000632021. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Ren K, Li Z, Li Y, Zhang W and Han X:
Sulforaphene enhances radiosensitivity of hepatocellular carcinoma
through suppression of the NF-κB pathway. J Biochem Mol Toxicol.
31:2017. View Article : Google Scholar
|
|
194
|
Mohankumar K, Francis AP, Pajaniradje S
and Rajagopalan R: Synthetic curcumin analog: Inhibiting the
invasion, angiogenesis, and metastasis in human laryngeal carcinoma
cells via NF-κB pathway. Mol Biol Rep. 48:6065–6074. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Moghadamtousi SZ, Kadir HA, Paydar M,
Rouhollahi E and Karimian H: Annona muricata leaves induced
apoptosis in A549 cells through mitochondrial-mediated pathway and
involvement of NF-κB. BMC Complement Altern Med. 14:2992014.
View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Mohammad KS and Guise TA: Breaking down
barriers to chemoresistance: Role of chemotherapy-induced
osteoblastic Jagged1. Cancer Cell. 32:717–718. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Giuliani N, Colla S and Rizzoli V: New
insight in the mechanism of osteoclast activation and formation in
multiple myeloma: Focus on the receptor activator of NF-kappaB
ligand (RANKL). Exp Hematol. 32:685–691. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Liu S, Li DQ, Ye F and Zhang J: Research
progress in mechanism of action of p62 protein in primary bone
tumors. Medical Recapitulate. 26:2945–2950. 2020.(In Chinese).
|
|
199
|
Takeda T, Tsubaki M, Genno S, Tomita K and
Nishida S: RANK/RANKL axis promotes migration, invasion, and
metastasis of osteosarcoma via activating NF-κB pathway. Exp Cell
Res. 436:1139782024. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Dai W, Wu J, Shui Y, Wu Q, Wang J and Xia
X: NF-κB-activated oncogene inhibition strategy for cancer gene
therapy. Cancer Gene Ther. 31:1632–1645. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Han Z, Xu L, Wang A, Wang B, Liu Q, Liu H,
Liu Q, Gang Z, Yu S, Mu L, et al: UBE2S facilitates glioblastoma
progression through activation of the NF-κB pathway via attenuating
K11-linked ubiquitination of AKIP1. Int J Biol Macromol.
278:1344262024. View Article : Google Scholar : PubMed/NCBI
|
